Detalhe da pesquisa
1.
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
Int J Clin Oncol
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758397
2.
Brigatinib in Japanese patients with ALK-positive non-small-cell lung cancer: Final results of the phase 2 J-ALTA trial.
Cancer Sci
; 114(9): 3698-3707, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434391
3.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877583
4.
Necitumumab plus gemcitabine and cisplatin in previously treated lung squamous cell carcinoma.
Invest New Drugs
; 41(1): 168-172, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331673
5.
[Efficacy and Safety Analysis of Selpercatinib in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer-Results from the Japanese Subset of a Global Phase 1/2 Study].
Gan To Kagaku Ryoho
; 49(6): 669-675, 2022 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-35799394
6.
Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Cancer Immunol Immunother
; 70(6): 1745-1753, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33389013
7.
Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
Ann Surg Oncol
; 28(6): 3046-3054, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33084992
8.
Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer.
Ann Surg Oncol
; 28(2): 685-694, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676867
9.
Predictive and prognostic impact of primary tumor-bearing lobe in nonsmall cell lung cancer patients treated with anti-PD-1 therapy.
Int J Cancer
; 147(8): 2327-2334, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356560
10.
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
Cancer
; 126(16): 3648-3656, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32484914
11.
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.
Cancer
; 126(1): 219-227, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31503343
12.
Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Oncologist
; 25(6): 475-e891, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31649134
13.
Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?
Surg Today
; 49(3): 197-205, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610361
14.
Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
Int J Clin Oncol
; 19(4): 601-6, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24158772
15.
Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic Chemotherapy Together With Nivolumab Plus Ipilimumab: A Case Report.
J Thorac Oncol
; 19(2): 337-343, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37943237
16.
Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-Asia.
Lung Cancer
; 191: 107798, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669727
17.
Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
Jpn J Clin Oncol
; 43(10): 1018-22, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23917962
18.
Phase 1 study of DS-1205c combined with gefitinib for EGFR mutation-positive non-small cell lung cancer.
Cancer Med
; 12(6): 7090-7104, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36621830
19.
Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Single Arm Phase 2 Trial: DRAGON Study (WJOG9416L).
JTO Clin Res Rep
; 4(10): 100569, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822699
20.
Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors.
Target Oncol
; 17(5): 597-604, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087188